Cargando…

Association of Adrenal Function and Disease Severity in Community-Acquired Pneumonia

INTRODUCTION: Rapid and accurate risk stratification in patients with community-acquired pneumonia (CAP) is an unmet clinical need. Cortisol to dehydroepiandrosterone (DHEA) ratio was put forward as a prognostic marker in sepsis. We herein validated the prognostic value of the adrenal hormones DHEA,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller, Cornelia, Blum, Claudine A., Trummler, Michael, Stolz, Daiana, Bingisser, Roland, Mueller, Christian, Tamm, Michael, Mueller, Beat, Schuetz, Philipp, Christ-Crain, Mirjam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049821/ https://www.ncbi.nlm.nih.gov/pubmed/24910975 http://dx.doi.org/10.1371/journal.pone.0099518

Ejemplares similares

Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia
por: Schuetz, Philipp, et al.
Publicado: (2008)

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
por: Müller, Beat, et al.
Publicado: (2007)

Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke
por: Blum, Claudine A., et al.
Publicado: (2013)

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
por: Christ-Crain, Mirjam, et al.
Publicado: (2006)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients
por: Kutz, Alexander, et al.
Publicado: (2014)

Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study
por: Suter-Widmer, Isabelle, et al.
Publicado: (2012)

Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial
por: Raess, Natalie, et al.
Publicado: (2021)

Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial
por: Blum, Claudine A, et al.
Publicado: (2014)

Association of adrenal insufficiency with patient-oriented health-care outcomes in adult medical inpatients
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
por: Schuetz, Philipp, et al.
Publicado: (2010)

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study
por: Sbiti-Rohr, Diana, et al.
Publicado: (2016)

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study
por: Nickler, Manuela, et al.
Publicado: (2017)

No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial
por: Borisov, Angel N., et al.
Publicado: (2022)

Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department
por: Fiumefreddo, Rico, et al.
Publicado: (2009)

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia
por: Baumgartner, Thomas, et al.
Publicado: (2018)

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia
por: Vögeli, Alaadin, et al.
Publicado: (2017)

Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study
por: Zurfluh, Seline, et al.
Publicado: (2018)

Mannose-Binding Lectin Deficiency Is Associated With Smaller Infarction Size and Favorable Outcome in Ischemic Stroke Patients
por: Osthoff, Michael, et al.
Publicado: (2011)

BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events
por: Nigro, Nicole, et al.
Publicado: (2014)

Hyponatremia and anti-diuretic hormone in Legionnaires’ disease
por: Schuetz, Philipp, et al.
Publicado: (2013)

Copeptin Levels Remain Unchanged during the Menstrual Cycle
por: Blum, Claudine A., et al.
Publicado: (2014)

Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study
por: Blum, Claudine Angela, et al.
Publicado: (2017)

Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia
por: Christ-Crain, Mirjam, et al.
Publicado: (2010)

Infection biomarkers in primary care patients with acute respiratory tract infections–comparison of Procalcitonin and C-reactive protein
por: Meili, Marc, et al.
Publicado: (2016)

Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study
por: Odermatt, Jonas, et al.
Publicado: (2017)

Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
por: Blum, CA, et al.
Publicado: (2015)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage
por: Zweifel, Christian, et al.
Publicado: (2010)

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
por: Ebrahimi, Fahim, et al.
Publicado: (2021)

Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Pre-analytic factors and initial biomarker levels in community- acquired pneumonia patients
por: Kutz, A, et al.
Publicado: (2014)

Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis
por: Schuetz, Philipp, et al.
Publicado: (2012)

Biomarkers and clinical scoring systems in community-acquired pneumonia
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease
por: Schuetz, Philipp, et al.
Publicado: (2008)

Prognostic value of procalcitonin in respiratory tract infections across clinical settings
por: Kutz, Alexander, et al.
Publicado: (2015)

Adrenal function testing in dialysis patients – a review of the literature
por: Brotzer, Lara, et al.
Publicado: (2021)

Risk of Adverse Clinical Outcomes in Hyponatremic Adult Patients Hospitalized for Acute Medical Conditions: A Population-Based Cohort Study
por: Kutz, Alexander, et al.
Publicado: (2020)

Copeptin, Procalcitonin and Routine Inflammatory Markers–Predictors of Infection after Stroke
por: Fluri, Felix, et al.
Publicado: (2012)

Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies
por: Wittermans, Esther, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ff5ntv4cpk3qlbf7r13lfgohh